American Century Companies’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45M | Buy |
813,995
+128,171
| +19% | +$7.08M | 0.02% | 721 |
|
|
2025
Q1 | $33.2M | Sell |
685,824
-242,462
| -26% | -$11.7M | 0.02% | 799 |
|
|
2024
Q4 | $35.8M | Buy |
928,286
+353,511
| +62% | +$13.6M | 0.02% | 776 |
|
|
2024
Q3 | $25.9M | Buy |
574,775
+547,464
| +2,005% | +$24.6M | 0.02% | 908 |
|
|
2024
Q2 | $946K | Sell |
27,311
-133,009
| -83% | -$4.61M | ﹤0.01% | 2192 |
|
|
2024
Q1 | $4.64M | Buy |
160,320
+121,976
| +318% | +$3.53M | ﹤0.01% | 1482 |
|
|
2023
Q4 | $879K | Buy |
+38,344
| New | +$879K | ﹤0.01% | 2125 |
|
|
2023
Q3 | – | Sell |
-14,339
| Closed | -$396K | – | 2885 |
|
|
2023
Q2 | $396K | Sell |
14,339
-1,278
| -8% | -$35.3K | ﹤0.01% | 2309 |
|
|
2023
Q1 | $351K | Buy |
15,617
+4,561
| +41% | +$103K | ﹤0.01% | 2248 |
|
|
2022
Q4 | $121K | Buy |
+11,056
| New | +$121K | ﹤0.01% | 2431 |
|
|
2019
Q1 | – | Sell |
-113,155
| Closed | -$762K | – | 1298 |
|
|
2018
Q4 | $762K | Sell |
113,155
-34,921
| -24% | -$235K | ﹤0.01% | 1078 |
|
|
2018
Q3 | $1.52M | Hold |
148,076
| – | – | ﹤0.01% | 1060 |
|
|
2018
Q2 | $995K | Buy |
148,076
+5,242
| +4% | +$35.2K | ﹤0.01% | 1105 |
|
|
2018
Q1 | $1.23M | Buy |
+142,834
| New | +$1.23M | ﹤0.01% | 1064 |
|